First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2

Clinical trial NCT07593209 · RECRUITING

Trial details

NCT number: NCT07593209
Sponsor: First Hospital of China Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

Malignant Tumor

Start date: 2026-05-01
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.